22.11.2016 • News

DuPont Supplies Enzymes to Miavit

(c) photosbyjim/Getty Images
(c) photosbyjim/Getty Images

DuPont Industrial Biosciences will supply its Fibrezyme G4 enzymes to Miavit, a German provider of feedstuffs, supplement, minerals and vitamins. Miavit will use the enzymes in MiaMethan ProCut, its new biogas ingredient for the agricultural sector. Fibrezyme G4 is said to help reduce the viscosity of poorly digestible materials by more than 60%, thus allowing faster processing time.

“As new technology like Fibrezyme comes online, we see tremendous opportunity for our customers to improve efficiency and yields. This, in turn, provides the emerging biogas industry a new revenue stream, particularly for rural and farm communities, from materials that would ordinarily go to waste – reducing damaging environmental impacts and expanding renewable options for power generation,” said Franz Otten, Miavit’s managing director of sales.

Enzymes work by accelerating the breakdown of various materials, such as plant fibers and animal and food waste, into sugars and amino acids, which are more suitable for conversion into biogas. Methane biogas is primarily used to generate renewable electricity, or is compressed and inserted into the gas pipeline grid.

DuPont entered the growing biogas sector in July of this year with the launch of Optimash AD-100, a liquid enzyme that can increase biogas yields in anaerobic digesters by as much as 13%. Fibrezyme G4 was originally launched by Florida-based biotechnology company Dyadic in April 2014. Dyadic sold its industrial technology assets to DuPont Industrial Biosciences for $75 million in January 2016, having decided to focus exclusively on its biopharmaceutical business.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read